Vector Biomed is a private other pharmaceuticals and biotechnology company. It has raised $15 million across 1 recorded round; the latest was a $15 million Series A in Jan 2023.
Last price · $/share
—
Implied valuation
—
Total raised
$15.0M
Last round
Early Stage VC (Series A)
Jan 2023
Team — not yet on record
No current team members for Vector Biomed are on record yet. People surface from round filings, company disclosures, and coverage sessions.
Pro members can request priority coverage with a 48-hour turnaround.
Free account
More of Vector Biomed with a free account
·Watch Vector Biomed: the Monday email on marks, rounds and moves
